Inhibrx

0 followers


Anchored by our protein-engineering expertise and our proprietary single-domain antibody platform, we’ve developed a unique pipeline of therapeutic candidates.

Industries

Headquarters

Stage

Employees

Links

Org chart

Mark P. Lappe
Founder & CEO

Mark P. Lappe

Collapse
Brendan P. Eckelman
Founder, EVP & Chief Scientific Officer
Kelly Deck
EVP & CFO
Jeffrey Jensen
EVP & Chief Clinical Development Officer
Ashraf Amanullah
EVP & Chief Technical Operations Officer
David Matly
EVP & Chief Commercial Officer
Leah Pollema
VP & General Counsel
Carlos Bais
EVP, Translational Sciences
David Kao
VP, Regulatory Affairs
Vasily Andrianov
VP, Clinical Development & Medical Affairs
Dana Ebbets-Reed
VP, Quality Assurance
Darren Brown
VP, Analytical Development & Quality Control
Robert Boothroyd
VP, Medical Affairs & Business Development
Brian Lobo
VP, Formulation Development & Drug Product Manufacturing
Charbel Helaihel
VP, Marketing & Commercial Planning
Melissa Masterson
VP, Value, Access & Distribution